1. Home
  2. PAXS vs DNA Comparison

PAXS vs DNA Comparison

Compare PAXS & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PIMCO Access Income Fund of Beneficial Interest

PAXS

PIMCO Access Income Fund of Beneficial Interest

HOLD

Current Price

$15.90

Market Cap

697.2M

Sector

Finance

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$9.74

Market Cap

607.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAXS
DNA
Founded
2021
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
697.2M
607.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PAXS
DNA
Price
$15.90
$9.74
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$10.50
AVG Volume (30 Days)
195.0K
879.7K
Earning Date
01-01-0001
02-24-2026
Dividend Yield
11.72%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$180,606,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.57
$5.00
52 Week High
$15.93
$17.58

Technical Indicators

Market Signals
Indicator
PAXS
DNA
Relative Strength Index (RSI) 58.83 53.36
Support Level $15.68 $8.82
Resistance Level $16.00 $11.10
Average True Range (ATR) 0.18 0.62
MACD 0.03 0.07
Stochastic Oscillator 74.81 40.35

Price Performance

Historical Comparison
PAXS
DNA

About PAXS PIMCO Access Income Fund of Beneficial Interest

PIMCO Access Income Fund is a non-diversified, limited-term, closed-end management investment company. The fund seeks current income as an objective and capital appreciation as a secondary objective. It achieves the investment objectives by utilizing a dynamic asset allocation among multiple sectors in the public and private credit markets, including corporate debt.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: